Trials / Unknown

UnknownNCT06117293

Safety and Efficacy Evaluation of the Mosaic Ultra Device

Status: Unknown
Phase: N/A
Study type: Interventional
Enrollment: 200 (estimated)

Sponsor: CynosureLutronic · Industry
Sex: All
Age: 18 Years – 60 Years
Healthy volunteers: Accepted

Summary

Evaluate the Safety and Efficacy of the Mosaic Ultra 1550nm system for the treatment of skin tone and texture, facial rejuvenation, photoaging, wrinkles, scars, stretch marks, acne vulgaris and hair loss.

Conditions

Skin Texture Disorder
Photoaging
Wrinkle
Scar
Stretch Mark
Acne Vulgaris
Hair Loss

Interventions

Type	Name	Description
DEVICE	Mosaic	1550 Fractional Laser System

Timeline

Start date: 2023-02-21
Primary completion: 2024-09-01
Completion: 2025-09-01
First posted: 2023-11-07
Last updated: 2023-11-07

Locations

3 sites across 1 country: United States

Regulatory

FDA-regulated device study

Source: ClinicalTrials.gov record NCT06117293. Inclusion in this directory is not an endorsement.